Clinical Trials Logo

Hormone Disturbance clinical trials

View clinical trials related to Hormone Disturbance.

Filter by:

NCT ID: NCT06451367 Not yet recruiting - Sport Injury Clinical Trials

Cardiovascular and Endocrine Response to Muscular Training Program of Young Soccer Players Aged 14-18 Years

YoungSoccer
Start date: June 1, 2024
Phase: N/A
Study type: Interventional

This study focuses on understanding the cardiovascular and endocrine responses of young soccer players aged 14 to 18 years to a muscular training program. Adolescence is a critical period for physiological development, and investigating these responses can provide insights crucial for athletic performance and overall health. The benefits include promoting overall health, reducing injury risk, and enhancing scientific knowledge. However, intensive training programs may lead to overtraining and potential negative health outcomes if not carefully monitored. The study aims to assess whether additional neuromuscular development over 12 weeks can enhance players' physical fitness and hormonal changes. By examining these outcomes, the study seeks to inform evidence-based training protocols for optimizing adolescent athletes' health and performance in soccer. The study design involves a prospective single-center randomized cohort to investigate these responses comprehensively.

NCT ID: NCT05790772 Completed - Hormone Disturbance Clinical Trials

Biochemical Changes in Blood Plasma After Intense Physical Exercise of Healthy Volunteers

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

This study will recruit 20 male and female athletes of endurance training background. They will participate in 50 minutes of vigorous activity on a treadmill with 3 blood draws (before exercising, 50 minutes into exercising, and 30 minutes after completion of exercising). After collection of the blood samples, the results will be analyzed for extracellular vesicles and biochemical changes within said extracellular vesicles.

NCT ID: NCT05518006 Withdrawn - Hormone Disturbance Clinical Trials

An Investigation of Premama Balance and Its Effects on Hormonal Imbalances

Start date: December 30, 2022
Phase: N/A
Study type: Interventional

An investigation of the dietary supplement marketed as "Premama Balance" on markers of subjective wellbeing in trial participants such as common symptoms of PMS and menstrual symptoms, as well as its effects on aiding in returning to their perceived regular/normal menstrual cycle.

NCT ID: NCT05328609 Completed - Hormone Disturbance Clinical Trials

An Exploratory Investigation of Dietary Supplementation and the Effect on Common Symptoms of Hormonal Imbalance

Start date: March 15, 2022
Phase: N/A
Study type: Interventional

This is an open-label observational trial to study the effectiveness of a commercial dietary supplement and its effect on common symptoms of normal menstrual discomfort.

NCT ID: NCT05033574 Active, not recruiting - Clinical trials for Epidermolysis Bullosa

The State of Sexual Development in Children With Inherited Epidermolysis Bullosa

Start date: December 8, 2020
Phase:
Study type: Observational

The aim of the study is to determine the state of sexual development in patients with inherited epidermolysis bullosa; the study is planned to include boys and girls aged 8 to 18 years with a diagnosis of epidermolysis bullosa simplex, junctional epidermolysis bullosa, Kindler syndrome.

NCT ID: NCT04766203 Recruiting - Eating Disorders Clinical Trials

Relative Energy Deficiency in Sport Multicenter Study

Start date: May 5, 2021
Phase: N/A
Study type: Interventional

Relative Energy Deficiency in Sport (RED-S) characterizes a range of negative health and performance outcomes that result from chronically low energy availability. RED-S concerns high performance junior and senior athletes across Canada and has a prevalence rate of 3-60%. Our ability to assess and diagnose RED-S remains poor. Accordingly, we aim to create the best parameters to diagnose and manage RED-S; along with information of the prevalence and severity across Canada and globally. These outcomes are expected to have a significant positive impact on the health and performance of Canadian athletes in preparation for the Olympic Games in 2022 and beyond.

NCT ID: NCT04643522 Completed - Covid19 Clinical Trials

Semen Parameters and COVID-19 in Infertile Men

Start date: January 7, 2020
Phase:
Study type: Observational

Coronavirus Disease-19 (COVID-19) is a global pandemics which affects many organs and systems with a range of morbidities and high mortality rates. There are a number of studies revealed that COVID-19 may affect the testes and male genital tract which may in turn disrupt the gonadal functions.The current study aimed to evaluate the effect of COVID-19 on semen parameters and sex-related hormone levels.

NCT ID: NCT04535973 Completed - Quality of Life Clinical Trials

Hormonal Status and Quality of Life in Female Postmenopausal Patients With Burning Mouth Syndrome

Start date: November 15, 2019
Phase:
Study type: Observational

The aim of this study was to determine the level of salivary estradiol, progesterone and dehydroepiandrosterone in female postmenopausal women with and without burning mouth syndrome. In all participants the quantity of unstimulated and stimulated saliva would be determined and they would fulfill self-perceived quality of life questionnaire Oral Health Impact Profile-14 (OHIP-14). Intensity of burning symptoms would be determined on visual-analogue scale grading 0-10. All data would be compared between study and control group.

NCT ID: NCT04447677 Completed - Hormone Disturbance Clinical Trials

Oocyte Retrieval Progesterone Levels and IVF

Start date: January 1, 2015
Phase:
Study type: Observational [Patient Registry]

Objective: To assess whether basal hormonal level can predict the elevation of P4 on the day of oocyte retrieval, as well as to examine the impact of P4 elevation on the day of oocyte retrieval on the outcome of assisted reproduction. Design: Prospective cohort study Setting: Department of In Vitro Fertilization, Gynecology and Obstetrics Institute, Clinical Center of Serbia Patient(s): One hundred sixty four patients enrolled in the ART procedure Main Outcome Measure(s): Pregnancies, miscarriages, biochemical pregnancies and deliveries

NCT ID: NCT04444245 Active, not recruiting - Hormone Disturbance Clinical Trials

Ovarian Rejuvenation Using Platelet Rich Plasma (PRP) & Autologous Tissue Stromal Vascular Fraction (tSVF) and Cell Enriched tSVF

OVAR-REJUV
Start date: July 15, 2022
Phase: Phase 1
Study type: Interventional

Trial of imaging guided intra-ovarian injection to improve ovarian function in clinical settings of Premature Ovarian Failure, Perimenopausal and /or early postmenopausal symptomatology and related hormonal deficiencies. The study will compare the effectiveness of autologous Platelet Rich Plasma alone versus Stromal Vascular Fraction (tSVF and/or cellular stromal vascular fraction (cSVF) in combination with Platelet Rich Plasma as regards efficacy and duration of ovarian reactivation in women with acquired Premature Ovarian Failure, Menopausal, and Perimenopausal women.